Glycyrrhetinic acid protects mice from Staphylococcus aureus pneumonia

Fitoterapia. 2012 Jan;83(1):241-8. doi: 10.1016/j.fitote.2011.10.018. Epub 2011 Nov 7.

Abstract

In the present study, the antimicrobial activity of glycyrrhetinic acid (GA) against Staphylococcus aureus, and its influence on the production of S. aureus alpha-haemolysin (Hla) were investigated, along with the in vivo activity of GA against S. aureus-induced pneumonia. GA could not inhibit the growth of S. aureus, but the secretion of Hla by S. aureus was significantly inhibited by low concentrations of GA in a dose-dependent manner. Furthermore, in vivo data show that GA provides protection against staphylococcal pneumonia in a murine model system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Cell Line, Tumor
  • Glycyrrhetinic Acid / pharmacology*
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Pneumonia, Bacterial / microbiology
  • Pneumonia, Bacterial / prevention & control*
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Staphylococcal Infections / microbiology*
  • Staphylococcal Infections / prevention & control*
  • Staphylococcus aureus

Substances

  • Anti-Bacterial Agents
  • Glycyrrhetinic Acid